Liver allocation policies for hepatocellular carcinoma have leveled the playing field—But who should be playing?
Allison J. Kwong, Neil Mehta – 11 August 2022
Reply
Yi‐Te Lee, Yazhen Zhu, Ju Dong Yang, Vatche G. Agopian, Hsian‐Rong Tseng – 10 August 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 10 August 2022
Fibroblasts to hepatocytes: A nonstop flight into cell therapy for liver diseases?
Valerie Gouon‐Evans, Romina Fiorotto – 10 August 2022
Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action
Jie Li, Mindie H. Nguyen – 10 August 2022
Reply
Laurens A. Kleef, Milan J. Sonneveld, Robert J. Knegt – 10 August 2022
Letter to the editor: Focus on metabolic dysfunction–associated fatty liver disease, even if patients have a history of excessive alcohol consumption
Shi‐Tao Jiang, Yi‐Yao Xu, Xin Lu – 10 August 2022
Intrahepatic paracrine signaling by cardiotrophin‐like cytokine factor 1 ameliorates diet‐induced NASH in mice
Tongyu Liu, Qiuyu Wang, Linkang Zhou, Peng Zhang, Lin Mi, Xiaoxue Qiu, Zhimin Chen, Henry Kuang, Siming Li, Jiandie D. Lin – 10 August 2022
Reply
Laurens A. Kleef, Robert J. Knegt, Willem Pieter Brouwer – 9 August 2022
Letter to the editor: Fatty liver and mortality in populations who are elderly
Yanrong Sun, Junwei Zhang, Hanfei Wang, Wenjuan Wang, Huiru Ding, Yiyao Xu, Lihua Qin – 9 August 2022